Quantification of fibroblast growth factor 23 and N-terminal pro-B-type natriuretic peptide to identify patients with atrial fibrillation using a high-throughput platform: A validation study.
Saved in:
| Title: | Quantification of fibroblast growth factor 23 and N-terminal pro-B-type natriuretic peptide to identify patients with atrial fibrillation using a high-throughput platform: A validation study. |
|---|---|
| Authors: | Chua, Winnie1 (AUTHOR), Law, Jonathan P.1,2 (AUTHOR), Cardoso, Victor R.1,3 (AUTHOR), Purmah, Yanish1,4,5 (AUTHOR), Neculau, Georgiana4,5 (AUTHOR), Jawad-Ul-Qamar, Muhammad1,4,5 (AUTHOR), Russell, Kalisha5 (AUTHOR), Turner, Ashley5 (AUTHOR), Tull, Samantha P.1 (AUTHOR), Nehaj, Frantisek1,5 (AUTHOR), Brady, Paul1,4,5 (AUTHOR), Kastner, Peter6 (AUTHOR), Ziegler, André7 (AUTHOR), Gkoutos, Georgios V.3 (AUTHOR), Pavlovic, Davor1 (AUTHOR), Ferro, Charles J.1,2 (AUTHOR), Kirchhof, Paulus1,4,5,8,9 (AUTHOR), Fabritz, Larissa1,4,8 (AUTHOR) L.Fabritz@bham.ac.uk |
| Source: | PLoS Medicine. 2/3/2021, Vol. 18 Issue 2, p1-17. 17p. 1 Diagram, 5 Charts, 4 Graphs. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 15491277 |
|---|---|
| DOI: | 10.1371/journal.pmed.1003405 |
